These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 7184431

  • 1. [Combination chemotherapy of cyclophosphamide adriamycin and 5-fluorouracil (CAF) in advanced and recurrent breast cancer].
    Abe O, Izuo M, Enomoto K, Kubo K, Koyama H, Sakai K, Terasawa T, Tominaga T, Nomura Y.
    Gan To Kagaku Ryoho; 1982 May; 9(5):866-73. PubMed ID: 7184431
    [Abstract] [Full Text] [Related]

  • 2. [Clinical evaluation of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) on advanced and recurrent breast cancer. Clinical study group of CMF for breast cancer in Japan].
    Nomura Y, Tominaga T, Adachi I, Koyama H, Fukami A.
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):1949-56. PubMed ID: 8085846
    [Abstract] [Full Text] [Related]

  • 3. [Results of clinical trials with a CMitF (cyclophosphamide, mitoxantrone, and 5-fluorouracil) regimen versus a CAF (cyclophosphamide, adriamycin, and 5-fluorouracil) regimen in advanced/relapsed breast cancer].
    Taguchi T, Sakai K, Terasawa T, Wada H.
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2820-8. PubMed ID: 3530139
    [Abstract] [Full Text] [Related]

  • 4. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
    Inaji H, Sakai K, Oka T, Ozawa K, Saito Y, Senoo T, Taguchi T, Terasawa T, Nakao K, Mori T, Koyama H, Oshima A.
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Effect of CAF'-endocrine therapy on advanced and recurrent breast cancer].
    Une Y, Sato Y, Kagaya H, Miyata S, Matsuoka S, Uchino J, Yakura Y.
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2778-81. PubMed ID: 6548892
    [Abstract] [Full Text] [Related]

  • 9. Combination chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in advanced breast carcinoma.
    Dalley DN, Levi JA, Aroney RS.
    Med J Aust; 1980 Mar 08; 1(5):216-8. PubMed ID: 6990214
    [Abstract] [Full Text] [Related]

  • 10. [Systemic chemotherapy of mammary carcinoma: plasma and tissue concentrations of 5-fluorouracil and adriamycin, and result of CAF and CMF therapy of breast cancer].
    Murayama Y, Nagashima M.
    Gan To Kagaku Ryoho; 1984 Mar 08; 11(3):415-9. PubMed ID: 6546655
    [Abstract] [Full Text] [Related]

  • 11. Dofequidar fumarate (MS-209) in combination with cyclophosphamide, doxorubicin, and fluorouracil for patients with advanced or recurrent breast cancer.
    Saeki T, Nomizu T, Toi M, Ito Y, Noguchi S, Kobayashi T, Asaga T, Minami H, Yamamoto N, Aogi K, Ikeda T, Ohashi Y, Sato W, Tsuruo T.
    J Clin Oncol; 2007 Feb 01; 25(4):411-7. PubMed ID: 17179098
    [Abstract] [Full Text] [Related]

  • 12. [Efficacy of combination therapy consisting of cyclophosphamide, adriamycin, UFT and oophorectomy/tamoxifen for advanced or recurrent breast cancer].
    Kiman K, Suzuki S, Satomi T, Sakonji M, Nihei M, Tanaka T, Kimijima I, Abe R.
    Gan To Kagaku Ryoho; 1994 Oct 01; 21(14):2445-52. PubMed ID: 7944490
    [Abstract] [Full Text] [Related]

  • 13. [Effects of DAC (doxifluridine, adriamycin, cyclophosphamide) chemotherapy in advanced breast cancer patients].
    Tashiro H, Takahashi I, Yamamura S, Ishikawa T, Yanaga K, Wakasugi K, Matsusaka T, Kume K.
    Gan To Kagaku Ryoho; 1999 May 01; 26(6):775-9. PubMed ID: 10410146
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [CMF or CAF combination chemotherapy for breast cancer].
    Ota J.
    Gan To Kagaku Ryoho; 1996 Dec 01; 23(14):1886-90. PubMed ID: 8978791
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [A case of far advanced breast cancer with distant metastases which had mostly disappeared after chemoendocrine therapy].
    Nishimura H, Takasuna K, Kondo R, Hayashi K, Munakata Y, Kasuga Y.
    Gan To Kagaku Ryoho; 2000 May 01; 27(5):753-7. PubMed ID: 10832447
    [Abstract] [Full Text] [Related]

  • 19. [Comparison of CAF plus MPA with CAF plus TAM for advanced or recurrent breast cancer--Kyushu CAFT Study Group of Advanced or Recurrent Breast Cancer].
    Mitsuyama S, Tashiro H, Koga T, Maehara Y, Ogawa M, Kakegawa T, Shimazu H, Sugimachi K, Tomita M, Nakamura Y.
    Gan To Kagaku Ryoho; 1995 Dec 01; 22(14):2073-80. PubMed ID: 8607618
    [Abstract] [Full Text] [Related]

  • 20. [A study on the efficacy of combination chemoendocrine therapy consisting of cyclophosphamide, adriamycin, UFT, and tamoxifen for advanced or recurrent breast cancer].
    Yamaguchi S, Fukuda M, Ota T, Nakayama Y, Ogata H, Shimizu K, Nishikawa T, Adachi Y, Fukuma E.
    Gan To Kagaku Ryoho; 1999 Jul 01; 26(8):1145-52. PubMed ID: 10431580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.